Notify me when Prosight Management, LP files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| STTK | Shattuck Labs, Inc. | Common Stock, $0.0001 par value per share | 9.9% | $15,638,344 | 6,543,240 | Prosight Management, LP | 30 Sep 2025 | ||
| ADCT | ADC THERAPEUTICS SA | Common Shares | 6.8% | $31,366,151 | +$4,743,267 | 8,477,338 | +18% | Prosight Management, LP | 31 Dec 2025 |
| OKUR | OnKure Therapeutics, Inc. | Class A Common Stock, par value $0.0001 per share | 5.8% | $2,214,578 | 745,649 | Prosight Management, LP | 24 Nov 2025 | ||
| JANX | Janux Therapeutics, Inc. | Common Stock, $0.001 par value per share | 5.3% | $43,569,636 | 3,157,220 | W. Lawrence Hawkins | 03 Feb 2026 | ||
| VINC | Vincerx Pharma, Inc. | Common Stock, $0.0001 par value per share | 5% | $7,823 | 111,755 | Prosight Management, LP | 31 Dec 2024 | ||
| MGTX | MeiraGTx Holdings plc | Ordinary Shares, $0.00003881 par value per share | 4% | $23,702,995 | -$8,448,499 | 3,211,788 | -26% | W. Lawrence Hawkins | 31 Dec 2025 |
| MURA | Mural Oncology plc | Ordinary Shares, nominal value $0.01 per share | 0% | $0 | -$1,862,820 | 0 | -100% | Prosight Management, LP | 30 Sep 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|